Concepedia

Publication | Open Access

Combination of Matrine and Sorafenib Decreases the Aggressive Phenotypes of Hepatocellular Carcinoma Cells

DOIFull Paper Access

19

Citations

28

References

2014

Year

Yan Lin, Lianjie Lin, Jin Yu, Ying Zhang, Dongxu Wang, Yue Tan, Chang-Qing Zheng
Chemotherapy

Abstract

Matrine in combination with sorafenib leads to increased cytotoxic effects against HCC cells, at least partially, via the suppression of miRNA-21 and the subsequent induction of PTEN.

References

YearCitations

Page 1